For help on how to get the results you want, see our search tips.
116 results
-
List item
Summary of opinion: Velactis (updated)
cabergoline, opinion date: 05/12/2019, Negative, Last updated: 06/12/2019 -
List item
Summary of opinion: Hopveus
sodium oxybate, opinion date: 17/10/2019, Negative, Last updated: 15/11/2019 -
List item
Summary of opinion: Translarna
ataluren, opinion date: 27/06/2019, Negative, Last updated: 18/10/2019 -
List item
Summary of opinion: Evenity
romosozumab, opinion date: 17/10/2019, Positive, Last updated: 18/10/2019 -
List item
Summary of opinion: Revolade
eltrombopag, opinion date: 17/10/2019, Negative, Last updated: 18/10/2019 -
List item
Summary of opinion: Venclyxto
venetoclax, opinion date: 20/09/2018, Positive, Last updated: 21/09/2018 -
List item
Summary of opinion: RoActemra
tocilizumab, opinion date: 20/09/2018, Positive, Last updated: 21/09/2018 -
List item
Summary of opinion: Trelegy Ellipta
fluticasone furoate / umeclidinium / vilanterol, opinion date: 20/09/2018, Positive, Last updated: 21/09/2018 -
List item
Summary of opinion: Respiporc FLUpan H1N1
inactivated influenza A virus/humanstrain: A/Jena/VI5258/2009(H1N1)pdm09, opinion date: 13/09/2018, Positive, Last updated: 14/09/2018 -
List item
Summary of opinion: Abseamed
epoetin alfa, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Epoetin Alfa Hexal
epoetin alfa, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Binocrit
epoetin alfa, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Xarelto
rivaroxaban, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: Symkevi
tezacaftor / ivacaftor, opinion date: 26/07/2018, Positive, Last updated: 27/07/2018 -
List item
Summary of opinion: RoActemra
tocilizumab, opinion date: 28/06/2018, Positive, Last updated: 29/06/2018 -
List item
Summary of opinion: Prolia
denosumab, opinion date: 26/04/2018, Positive, Last updated: 27/04/2018 -
List item
Summary of opinion: Perjeta
pertuzumab, opinion date: 26/04/2018, Positive, Last updated: 27/04/2018